Arkolith/Insider Trading/ANAB/Form 4

Lizzul Paul F.

Chief Medical OfficerANAPTYSBIO, INC (ANAB) · full profile →Form 4 · filed Jan 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$101K
Net Open-Market Flow
-$101K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Sell(S)2K$45.11$101K37K
Jan 6, 2026Option exercise(M)6K——39K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 6, 2026Grant(A)29K—$029K
Jan 6, 2026Grant(A)21K—$021K
Jan 6, 2026Option exercise(M)6K—$06K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001711462-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML